Diabetes and impaired glucose regulation in first-degree relatives of patients with type 2 diabetes in Isfahan, Iran: Prevalence and risk factors

Review of Diabetic Studies

Volumn 4, Issue 3, 2007, Pages 169-176

  Amini, Masoud ^a   Janghorbani, Mohsen ^a,b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

First degree relatives; Impaired glucose tolerance; Prevalence; Risk factors; Type 2 diabetes

Indexed keywords

GLUCOSE;

ABDOMINAL OBESITY; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IRAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; OUTPATIENT; PREVALENCE; RELATIVE; RISK FACTOR; SEX DIFFERENCE;

EID: 37849001441     PISSN: 16136071     EISSN: 16140575     Source Type: Journal    
DOI: 10.1900/RDS.2007.4.169     Document Type: Article

References (36)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004. 27:1047-1053.
2. Grill V, Persson G, Carlsson S, Norman A, Alvarsson M, Ostensson CG, Svanstrom L, Efendic S. Family history of diabetes in middle-aged Swedish men is a gender unrelated factor which associates with insulinopenia in newly diagnosed diabetic subjects. Diabetologia 1999. 42:15-23.
3. Park HS, Yim KS, Cho SI. Gender differences in familial aggregation of obesity-related phenotypes and dietary intake pattern in Korean families. Ann Epidemiol 2004. 14:486-491.
4. Li JK, Ng MC, So WY, Chiu CK, Ozaki R, Tong PC, Cockram CS, Chan JC. Phenotypic and genetic clustering of diabetes and metabolic syndrome in Chinese families with type 2 diabetes mellitus. Diabetes Metab Res Rev 2006. 22:46-52.
5. Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Cosegregation of obesity with familial aggregation of type 2 diabetes mellitus. Diabetes Obes Metab 2000. 2:149-154.
6. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003. 26(Suppl 1):S5-S20.
7. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P, Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003. 26(11):3160-3167.
8. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972. 18:499-502.
9. Waterhouse JA, Muir CS, Correa P, Powell J (eds.). Cancer incidence in five continents. IARC Scientific Publications, Lyon, France, 1976. Vol. 3, p. 456.
10. Azizi F. Diabetes mellitus in the Islamic republic of Iran. IDF Bull 1996. 41:38-93.
11. Azizi F, Guoya MM, Vazirian P, Dolatshati P, Habbibian S. Screening for type 2 diabetes in the Iranian national programme: a preliminary report. East Mediterr Health J 2003. 9(5-6):1122-1127.
12. Sadeghi M, Roohafza H, Shirani S, Poormoghadas M, Kelishadi R, Baghaii A, Sarraf-Zadegan N. Diabetes and associated cardiovascular risk factors in Iran: the Isfahan Healthy Heart Programme. Ann Acad Med Singapore 2007. 36(3):175-180.
13. Diabetes Atlas. International Diabetes Federation 2006. 3rd ed.
14. Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, Safaie A, Forouzanfar M, Gregg EW. Prevalence of Diabetes Mellitus and Impaired Fasting Glucose in the Adult Population of Iran: The National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care 2007. In press.
15. Stewart J, Kendrick D. Nottingham Diabetes Blood Pressure Study Group. Setting and negotiating targets in people with type 2 diabetes in primary care. Diabet Med 2005. 22:683-687.
16. Skyler JS, Oddo C. Diabetes trends in the USA. Diabetes Metab Res Rev 2002. 18(Supl 3):S21-26.
17. Bener A, Zirie M, Al-Rikabi A. Genetic, obesity, and environmental risk factors associated with type 2 diabetes. Croat Med J 2005. 46:302-307.
18. Yuturu S, Bridges JF, Dhanireddy RR. Preliminary evidence of genetic anticipation in type 2 diabetes mellitus. Med Sci Monit 2005. 11:262-265.
19. Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care 2003. 26(3):868-874.
20. Glumer C, Jorgensen T, Borch-Johnsen K. Prevalence of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 2003. 26:2335-2340.
21. Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B, Borch-Johnsen K, Ramachandran A, Mohan V, Iyer SR, Tominaga M, et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003. 26:1770-1780.
22. The DECODE Study Group. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts. Diabetes Care 2003. 26:61-69.
23. Williams JW, Zimmet PZ, Shaw JE, de Courten MP, Cameron AJ, Chitson P, Tuomilehto J, Alberti KG. Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius: does sex matter? Diabet Med 2003. 20:915-920.
24. Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. Diabetes 2004. 53:2095-2100.
25. Novoa FJ, Boronat M, Saavedra P, Diaz-Cremades JM, Varillas VF, La Roche F, Alberiche MP, Carrillo A. Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study. Diabetes Care 2005. 28:2388-2393.
26. Margolis KL, Bonds DE, Rodabough RJ, Tinker L, Phillips LS, Allen C, Bassford T, Burke G, Torrens J, Howard BV. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 2004. 47:1175-1187.
27. van Genugten RE, Utzschneider KM, Tong J, Gerchman F, Zraika S, Udayasankar J, Boyko EJ, Fujimoto WY, Kahn SE, American Diabetes Association GENNID Study Group. Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes. Diabetes 2006. 55:3529-3535.
28. Bonds DE, Lasser N, Qi L, Brzyski R, Caan B, Heiss G, Limacher MC, Liu JH, Mason E, Oberman A, et al. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomized trial. Diabetologia 2006. 49:459-468.
29. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, Zoli M, Marchesini G. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005. 42:473-480.
30. Kanaya AM, Herrington D, Vittinghoff E, Lin F, Grady D, Bittner V, Cauley JA, Barrett-Connor E. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study: a randomized, doubleblind, placebo-controlled trial. Ann Intern Med 2003. 38:1-9.
31. Duncan AC, Lyall H, Roberts RN, Petrie JR, Perera MJ, Monaghan S, Hart DM, Connell JM, Lumsden MA. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. J Clin Endocrinol Metab 1999. 84:2402-2407.
32. Davidson MH, Maki KC, Marx P, Maki AC, Cyrowski MS, Nanavati N, Arce JC. Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women. Arch Intern Med 2000. 160:3315-3325.
33. Vehkavaara S, Westerbacka J, Hakala-Ala-Pietila T, Virkamaki A, Hovatta O, Yki-Jarvinen H. Effect of estrogen replacement therapy on insulin sensitivity of glucose metabolism and preresistance and resistance vessel function in healthy postmenopausal women. J Clin Endocrinol Metab 2000. 85:4663-4670.
34. Selby JV, Newman B, Quesenberry CP Jr, Fabsitz RR, Carmelli D, Meaney FJ, Slemenda C. Genetic and behavior on body fat distribution. Int J Obes 1990. 14:593-602.
35. Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990. 10:223-231.
36. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucose and diabetes. Diabetes Care 1997. 20:915-942.